Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,314 | 144 | 94.1% |
| Education | $124.35 | 4 | 5.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $563.92 | 32 | $0 (2024) |
| PFIZER INC. | $492.52 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $456.86 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $193.10 | 11 | $0 (2024) |
| Gilead Sciences, Inc. | $124.74 | 9 | $0 (2024) |
| FUJIFILM Healthcare Americas Corporation | $92.20 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $84.79 | 5 | $0 (2024) |
| GENZYME CORPORATION | $70.76 | 4 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $67.66 | 4 | $0 (2017) |
| Celgene Corporation | $43.72 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $942.52 | 53 | ABBVIE INC. ($237.68) |
| 2023 | $399.91 | 25 | PFIZER INC. ($134.77) |
| 2022 | $327.34 | 15 | ABBVIE INC. ($139.59) |
| 2021 | $153.98 | 6 | Janssen Biotech, Inc. ($127.65) |
| 2020 | $67.59 | 5 | AbbVie Inc. ($38.77) |
| 2019 | $278.50 | 25 | Janssen Biotech, Inc. ($119.43) |
| 2018 | $133.88 | 10 | PFIZER INC. ($36.46) |
| 2017 | $154.62 | 10 | Takeda Pharmaceuticals America, Inc. ($67.66) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: VIROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: GALLSTONES | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.47 | General |
| 10/07/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Education | In-kind items and services | $8.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,313 | 1,443 | $1.3M | $167,482 |
| 2022 | 14 | 1,297 | 1,598 | $1.3M | $170,331 |
| 2021 | 14 | 1,489 | 1,765 | $1.3M | $180,319 |
| 2020 | 15 | 1,590 | 1,894 | $1.2M | $159,623 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 230 | 231 | $438,323 | $51,879 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 310 | 407 | $142,043 | $42,314 | 29.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 173 | 179 | $285,505 | $15,167 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 208 | $48,880 | $13,861 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $40,040 | $12,289 | 30.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 45 | 45 | $76,230 | $8,823 | 11.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 83 | 83 | $150,645 | $6,621 | 4.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $25,696 | $5,009 | 19.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 25 | 25 | $42,350 | $4,616 | 10.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $25,410 | $1,978 | 7.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $5,694 | $1,443 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 33 | $4,719 | $1,387 | 29.4% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 11 | 11 | $3,998 | $1,036 | 25.9% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 13 | 13 | $3,446 | $994.24 | 28.9% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 16 | 16 | $240.00 | $66.40 | 27.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 206 | 207 | $392,783 | $43,011 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 276 | 396 | $138,204 | $40,290 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 320 | 392 | $92,120 | $28,790 | 31.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 183 | 190 | $303,050 | $16,082 | 5.3% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 12 | 12 | $26,400 | $8,525 | 32.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 96 | 96 | $174,240 | $7,947 | 4.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $16,720 | $4,746 | 28.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 23 | 23 | $38,962 | $4,548 | 11.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $50,820 | $4,164 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $14,784 | $3,401 | 23.0% |
About Dr. Mitchell Schwartz, M.D
Dr. Mitchell Schwartz, M.D is a Gastroenterology healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174594089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Schwartz, M.D has received a total of $2,458 in payments from pharmaceutical and medical device companies, with $942.52 received in 2024. These payments were reported across 149 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,314).
As a Medicare-enrolled provider, Schwartz has provided services to 5,689 Medicare beneficiaries, totaling 6,700 services with total Medicare billing of $677,755. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Oakhurst, NJ
- Active Since 01/30/2006
- Last Updated 03/31/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1174594089
Products in Payments
- XELJANZ (Drug) $407.86
- STELARA (Biological) $356.24
- RINVOQ (Biological) $194.16
- Entyvio (Biological) $102.47
- ENTYVIO (Biological) $99.42
- SKYRIZI (Biological) $94.10
- FUJIFILM (Device) $92.20
- DUPIXENT (Biological) $88.62
- INJECTAFER (Drug) $84.79
- VELSIPITY (Drug) $68.69
- TREMFYA (Drug) $64.97
- EOHILIA (Drug) $49.13
- ZEPOSIA (Drug) $43.72
- HUMIRA (Biological) $40.09
- CREON (Drug) $36.90
- Creon (Drug) $36.75
- REMICADE (Biological) $35.65
- XIFAXAN (Drug) $33.30
- CIMZIA (Drug) $26.82
- LINZESS (Drug) $21.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oakhurst
Laleh Merikhi, M.d, M.D
Gastroenterology — Payments: $13,511
Ben Terrany, Md, MD
Gastroenterology — Payments: $9,191
Junsuke Maki, Md, MD
Gastroenterology — Payments: $6,862
Shamina Dhillon, M.d, M.D
Gastroenterology — Payments: $2,446
Dr. Penny Turtel, Md, MD
Gastroenterology — Payments: $2,429
Alexander Browne, M.d, M.D
Gastroenterology — Payments: $2,305